Coronary Disease Clinical Trials
Myocardial Ischemia and Transfusion (MINT)
View Myocardial Ischemia and Transfusion (MINT) information
The purpose of this study is to assess among patients with an acute myocardial infarction and a hemoglobin concentration less than 10 g/dL, if a liberal transfusion strategy with a threshold of 10 g/dL reduces the rate of the composite outcome of all-cause mortality or recurrent nonfatal acute myocardial infarction through 30 days following randomization compared to a restrictive transfusion strategy with a threshold of 7 to 8 g/dL.
Primary Investigator: Michael Gitter, MD
Subinvestigators: Matthew Karafin, MD; Nicole Lohr, MD, PhD; David S. Marks, MD, MBA
Status: Currently enrolling
Sub Category: General Cardiology
Meet Our Team
Michael J. Gitter, MD, FACC
Associate Professor
Matthew Karafin, MD, MS
Associate Professor
Nicole Lohr, MD, PhD, FACC
Associate Professor, Medical Director Cardiovascular Clinical Trials
David S. Marks, MD, MBA
Professor of Medicine and Radiology, Vice Chair for Clinical Affairs, Froedtert Hospital Senior Medical Director - Inpatient
Cardiovascular Clinical Trials
The Cardiovascular Research Service is currently conducting drug and/or device trials in the cardiac subspecialties listed. However, this does not limit what we may be working on tomorrow.
Please contact the Cardiovascular Trials program by calling (414) 955-7021 or at DOMCVClinTriStaff@mcw.edu.